Craig Thompson

Dr. Craig B. Thompson, MD, is an Independent Director at Charles River Laboratories International, Inc., an Independent Director at Regeneron Pharmaceuticals, Inc., a Member at American Academy of Arts & Sciences, a Member at American Association of Physicists In Medicine, a Member at American Society for Clinical Investigation, a Member at Association of American Physicians, a Member at National Academy of Medicine (United States) and a Member at National Academy of Sciences.
He is on the Board of Directors at Charles River Laboratories International, Inc., Regeneron Pharmaceuticals, Inc., Memorial Sloan Kettering Cancer Center, American Association for Cancer Research, City of Hope Comprehensive Cancer Center, New York Genome Center, Ohio State University Comprehensive Cancer Center, The University of Texas M.D.
Anderson Cancer Center and The Economic Club of New York.
Dr. Thompson was previously employed as an Independent Director by Merck & Co., Inc., a Co-Founder by Agios Pharmaceuticals, Inc., an Associate Vice President-Cancer Services by The University of Pennsylvania Health System, a Professor by University of Pennsylvania, a Professor by Perelman School of Medicine, a Professor by University of Michigan, a Professor by Uniformed Services University of the Health Sciences, a President, Chief Executive Officer & Director by Memorial Sloan-Kettering Cancer Center (Investment Management), and a President & Chief Executive Officer by The Society of Memorial Sloan-Kettering Cancer Center.
He also served on the board at Charles River Laboratories, Inc., Schering-Plough Corp.
USA, Abramson Cancer Center and Howard Hughes Medical Institute, Inc. He received his undergraduate degree from Dartmouth College and a doctorate degree from the University of Pennsylvania.